260%

Clin-e-cal uses its patented Sound Response technology to develop apps to provide real-time feedback to inhaler users & facilitate remote disease management. With thousands of downloads, they're on a mission to help the world’s 500m asthma & COPD sufferers. Raising to commercialise & scale-up activities.

  • Mission is to solve some of longest-standing problems in respiratory medicine
  • Won competitive grants (and short-listed for Tech4Good award 2020)
  • Available on NHS digital app store and rated 79% by ORCHA assessment
  • Granted US/ EU patents protecting core Sound Response methods

Idea

Clin-e-cal started with our founder, Tariq Aslam, solving problems he had giving inhaler medication to his young son - Rafi. He realised his wasn’t a unique problem and Rafi-Tone, the solution he developed, had the potential to help many children using inhalers with a spacer. Since launching in 2016, the app, powered by our patented Sound Response engine, has had thousands of downloads across the UK, Australia, and Scandinavia.

We are now planning to advance the sound analysis technology to address problems in inhaler users of all ages. Currently undergoing beta testing, the first version of our new Clip-Tone Buddy app uses sound analysis to give real-time feedback, helping patients understand how to use their inhalers correctly. We have estimated a £300m near-term addressable opportunity and we are targeting pharma companies and inhaler manufacturers directly to build the user base and develop real-world insights.

We believe these insights can help transform care, providing healthcare professionals with detailed information on patients’ inhaler use. We strive for our data to ultimately help streamline clinical trials, identify patients most at risk and impact future respiratory device design.

We are raising now to progress commercialisation of the Clip-Tone Buddy, scale the sales activity and for additional support in marketing, regulatory and legal aspects of the business.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Clin-e-cal pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investing in start-ups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Crowdcube is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. You will only be able to invest via Crowdcube once you are registered as sufficiently sophisticated. Please click here to read the full Risk Warning.

Crowdcube is authorised and regulated by the Financial Conduct Authority (FCA) and the Comisión Nacional del Mercado de Valores (CNMV). This page has been approved by Crowdcube. Pitches for investment are not offers to the public and investments can only be made by members of crowdcube.com on the basis of information provided in the pitches by the companies concerned. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

Clin-e-cal has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.